SCHEDULE 13DAccepted Feb 5, 4:05 PM ET
Polaryx Therapeutics, Inc. SCHEDULE 13D
Accepted (ET)
4:05 PM
Feb 5, 2026
Filed
Feb 5, 2026
Documents
2
Size
22.0 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.